NLRP3 and diabetes mellitus: The present work designed to elucidate the evidence regarding the lung as the target organ for type 1 DM and the possible mechanism of action of vildagliptin and linagliptin in maintaining lung function and preventing pulmonary damage progression in male Sprague Dawley-rats with STZ-induced DM, especially through the NLRP3 inflammatory pathway.